MedTrace Logo

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

NCT00378950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 605

Last updated 2017-05-04

No results posted yet for this study

Summary

Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. This study will evaluate the effectiveness of an educational program developed for various levels of health literacy at improving medical outcomes and quality of life in individuals with HF.

Conditions

  • Heart Failure, Congestive

Interventions

BEHAVIORAL

Teach to Goal (TTG)

The TTG program includes the Brief Educational Intervention (BEI) educational intervention, as well as education about diuretic self adjustment. In addition, follow-up phone calls are given to the TTG group to further reinforce the initial training and provide further training so participants will master the task.

BEHAVIORAL

Brief Educational Intervention (BEI)

The BEI is a one hour educational session on CHF, symptom recognition, diet, exercise, and daily checkups.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Mike Pignone, MD, MPH · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00378950 on ClinicalTrials.gov